Biotehnologii inovatoare pentru refacerea sănătății solului și creșterea competitivității agricole

Orizont Europa

Pe scurt

Banii se acordă pentru dezvoltarea, testarea și validarea unor soluții biotehnologice inovatoare, precum fertilizatori bio-bazați sau inoculanți microbieni, care refac sănătatea solului, remediază solurile contaminate și cresc productivitatea culturilor. Proiectele trebuie să aducă aceste soluții până la nivel de pregătire pentru piață, demonstrând fezabilitatea economică și acceptarea de către fermieri și alte părți interesate. Pot aplica consorții formate din universități, organizații de cercetare, întreprinderi mici și mijlocii, start-up-uri, fermieri și alți actori ai lanțului de valoare, care trebuie să colaboreze prin abordarea multi-actor.

Grant per proiect

6.400.000 la 6.400.000 EUR

Buget total apel

12.800.000 EUR

Se deschide

04.02.2027

Tip de acțiune

HORIZON Innovation Actions

Eligibilitate România

Organizațiile din România pot aplica

Identificator apel

HORIZON-MISS-2027-05-SOIL-05-two-stage

Sursă

Portalul UE pentru finanțări (apeluri tematice)

Expected Outcome:Activities under this topic will advance the objectives and targets of the Mission Soil and should contribute to achieving the targets of the EU Soil Strategy for 2030, the EU Biodiversity Strategy for 2030, the Zero Pollution Action Plan, the proposal for a Soil Monitoring and Resilience Directive, the Life Science Strategy, the Communication on Boosting Biotechnology and Biomanufacturing in the EU, while also contributing to the objectives on improving soil management and environmental performance of the Vision for Agriculture and Food.Project results are expected to contribute to all the following expected outcomes:to advance, validate and bring up to market readiness level innovative, scalable, sustainable and cost-effective biotechnologies, particularly those leveraging soil microbiome, which enhance crop quality and productivity, while remediate soil pollution and improve soil health;validated, market ready biotechnological solutions for soil remediation and soil health improvement are made available to relevant stakeholders, to enable reduced dependency on synthetic chemicals, increased crop resilience and agricultural productivity. Scope:Europe faces increasing challenges due to soil degradation, loss of biodiversity, and the expanding impacts of climate change. Addressing these issues is essential to ensure food security and sustainable land use. The integration of biotechnology can play a transformative role in this regard in the varied environmental conditions and land-use types found across Europe. In addition biotechnology solutions that improve soil health (such as novel bio-based fertilizers or microbial inoculants) can significantly enhance crop productivity by restoring essential nutrients and microbial balance in the soil. Finally, biotechnology solutions can provide innovative methods to decontaminate and rehabilitate degraded soils and lands, thus boosting the ecological and economic value of underutilized areas.Proposals should:develop, identify, upscale, pilot and validate biotechnology solutions, particularly leveraging the soil microbiome (such as novel bio-based fertilizers or microbial inoculants but not only) which remediate, restore and improve soil health across diverse pedoclimatic and cropping conditions;address the following issues: bioremediation of contaminated soils (i.e. by heavy metals, pharmaceuticals, PFAS); increasing soil organic carbon stocks, improving soil structure to enhance soil biodiversity, water retention and nutrient availability; overall, this should lead to enhanced crop quality and productivity, enabled higher and more sustainable biomass production;ensure that developed solutions are scalable, sustainable, cost-effective and integrate circular economy principles to boost resource efficiency and support sustainable soil management practices;assess the economic, environmental and social impact of developed biotechnological solutions; analyse their socio-economic feasibility (including cost-benefit, adoption barriers, and market potential) and validate their scalability and market readiness through stakeholder collaboration (e.g. SMEs, farmers, industry); address challenges related to environmental stability and sustainability of the developed solutions and the adaptability to varying environmental conditions;design integrated market-readiness pathways for the developed biotechnology solutions, to accelerate their safe, effective, and socially accepted deployment. The pathways should ensure regulatory compliance including risk assessment considerations, stakeholder engagement strategies, market acceptance analysis and policy foresight. Proposals must implement the 'multi-actor approach' and ensure adequate involvement of all relevant actors of the value chain, such as academia, research-technology organizations, small-medium enterprises (including start-ups), investors, product developers, intellectual property and legal advisors, manufacturing and distribution partners, as well as end-users, like farmers and practitioners.Proposals should include a dedicated task, appropriate resources and a plan on how they will collaborate with other project funded under this topic and other relevant topics. They should participate in joint activities, workshops, focus groups or social labs, as well as organise common communication and dissemination activities and show potential for upscaling and cross-fertilisation. Applicants should plan the necessary budget to cover these activities.nullActivities are expected to achieve TRL 5-6 by the end of the project, see General Annex B.

General conditions1. Admissibility Conditions: Proposal page limit and layoutdescribed in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.2. Eligible Countriesdescribed in Annex B of the Work Programme General Annexes.A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.3. Other Eligible ConditionsProposals must apply the multi-actor approach. See definition of the multi-actor approach in the introduction to this work programme part.described in Annex B of the Work Programme General Annexes.4. Financial and operational capacity and exclusiondescribed in Annex C of the Work Programme General Annexes.5a. Evaluation and award: Award criteria, scoring and thresholdsare described in Annex D of the Work Programme General Annexes.5b. Evaluation and award: Submission and evaluation processesare described in Annex F of the Work Programme General Annexes and the Online Manual.5c. Evaluation and award: Indicative timeline for evaluation and grant agreementdescribed in Annex F of the Work Programme General Annexes.6. Legal and financial set-up of the grantsEligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme, the Framework Programme for Research and Innovation (2021-2027), and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].described in Annex G of the Work Programme General Annexes.Specific conditions described in the [specific topic of the Work Programme] Application and evaluation forms and model grant agreement (MGA): Application form templates, the application form specific to this call is available in the Submission SystemStandard application form (HE RIA, IA)Evaluation form templates, will be used with the necessary adaptations Standard evaluation form (HE RIA, IA) GuidanceHE Programme Guide Model Grant Agreements (MGA)Lump Sum MGA Call-specific instructions Detailed budget table (HE LS) Guidance: "Lump sums - what do I need to know?"Additional documents: HE Main Work Programme 2026-2027-1. General IntroductionHE Main Work Programme 2026-2027-12. MissionsHE Main Work Programme 2026-2027-15. General AnnexesHE Programme GuideHE Framework Programme 2021/695HE Specific Programme Decision 2021/764EU Financial Regulation 2024/2509Decision authorising the use of lump sum contributions under the Horizon Europe ProgrammeRules for Legal Entity Validation, LEAR Appointment and Financial Capacity AssessmentEU Grants AGA, Annotated Model Grant Agreement Funding & Tenders Portal Online Manual Funding & Tenders Portal Terms and Conditions Funding & Tenders Portal Privacy Statement

Apelul oficial

Condițiile din ghidul oficial sunt singurele care contează la depunere.

Program